← SynDRA
METYRAPONE
SynDRA canonical compound SYN0002669 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CYP11B1 |
|---|
| Mechanism of action | Cytochrome P450 inhibitor |
|---|
| Indication | adrenal diagnostic agent |
|---|
| Disease area | nephrology |
|---|
All known targets
- CYP11B1
- CYP11B2
- CYP3A4
- Cyp11b1
- HSD11B1
- NR3C2
Mechanisms of action (all sources)
- Cytochrome P450 inhibitor
- CYP11B1 INHIBITOR
- Cytochrome P450 11B1, mitochondrial inhibitor
- CYP11B2 INHIBITOR
Drug classes
- Antimetabolites
- Enzyme Inhibitors
- Noxae
- Adrenal Steroid Synthesis Inhibitors
- Adrenal Steroid Synthesis Inhibitor
ATC classes
- V04C · OTHER DIAGNOSTIC AGENTS
Cross-references
Synonyms
- mepyrapone
- methapyrapone
- methbipyranone
- methopirapone
- methopyrapone
- methopyrinine
- methopyrone
- metopiron
- metopirone
- metopyrone
- metroprione
- metyrapon
- Metirapona
- NSC-25265
- Metopiron
- Metopirone
- MYT
- Mepyrapone
- Metapirone
- Metapyron
- Methapyrapone
- Methbipyranone
- Methopirapone
- Methopyrapone
- Methopyrinine
- Methopyrone
- Metopyrone
- Metroprione
- Metyrapon
- Metyraponum
- Alliance Brand of Metyrapone
- Metyrapone Alliance Brand
- Metyrapone Novartis Brand
- Novartis Brand of Metyrapone
- Su-4885
- METOPIRONE (TN)
- Metirapona [INN-Spanish]
- Metyraponum [INN-Latin]
Reported adverse events
- Headache
- Hypotension
- Leukopenia
- Nausea
Look up METYRAPONE in the interactive SynDRA portal →